Migrants become commodities in Libya and sold into exploitation and slavery, a UN agency says. » Read More
By: Jeff Daniels
A semi-official Chinese paper is knocking Pyongyang's tech prowess after its communist neighbor's failed test missile launch. » Read More
By: Matt Hunter
The way to prepare for a more automated future is to know how to use technologies relevant to your work, said Google's Peter Norvig. » Read More
By: Kate Kelly
Nearly 300 executives have visited the White House this year, according to a New York Times tabulation. » Read More
In America, 44 million people have student debt, and 8 million of those borrowers are in default.
Ukraine's central bank Governor Valeria Gontareva tendered her resignation on Monday following a hate campaign and even death threats at a time when the country is enduring a deep recession.
The federal prison bureau's problems including sub-par inmate care didn't cut top employees' bonuses, USA Today reports.
Toyota says it's investing $1.3 billion to retool its sprawling Georgetown, Kentucky, factory where its flagship Camry sedans are built.
The influence of the newest Supreme Court justice, Neil Gorsuch, is likely to have an immediate effect on one of the most important cases yet to be heard.
A group of Twitter diehards started a petition encouraging the company to sell itself to its users, which would essentially turn Twitter into a co-op.
Twitter's top executives are very well paid, but that still didn't stop many from leaving the struggling social communications company.
Swift Transportation is merging with Knight Transportation in a share swap that would combine two of the biggest U.S. trucking operators.
Oreo cookie maker Mondelez is thinking about replacing for longtime CEO Irene Rosenfeld, according to a report in The Wall Street Journal.
Some of the most popular brands among teens are Snapchat, Chick-fil-A, Amazon, Nike, and Starbucks, a new survey shows.
Barclays has announced CEO Jes Staley is being investigated by two U.K. regulators regarding his individual conduct after he attempted to identify a whistleblower at the bank in 2016.
Google Inc has offered to invest at least 1 trillion won to help South Korea's LG Display Co Ltd boost output of OLED screens for smartphones.
Hungarians rose up in one of the largest protests against the seven-year rule of right-wing Prime Minister Viktor Orban on Sunday, protesting against new legislation that could force out of the country one of its top international universities.
The U.S. missile attack on Syria is unlikely to deter North Korea's nuclear-weapons development and could embolden the regime in Pyongyang.
In 2016, airlines posted their best numbers ever in critical areas like baggage handling and denied boardings.
Welcome back to the week ahead on Wall Street and a look at what investors need to know for the next five days.
On your next trip out o town, you might want to consider a luggage scooter, a $230 travel bag, or a jellybean scented purse.
K.T. McFarland is leaving her post and is expected to be tapped to become US ambassador to Singapore, The AP reports.
The key to success is often information gathering, Gurley said on Thursday from the LAUNCH Festival in San Francisco.
Even though Trump is at the center of this race, most contestants in the contest don't want to mention his name, NBC News reports.
Get the best of CNBC in your inbox
The Nobel Prize-winning economist is encouraging investors to go abroad as U.S. stocks hit fresh record highs.
Conditions are ripe to prepare for Korean peninsula unification, said Bruce Bennett, senior defense analyst at Rand.
It's also a complicated issue that will take a lot of continuing work because of the consequences of direct military action, Panetta said.
It seems that everyone in Silicon Valley is trying out this low carb, high fat diet. CNBC speaks with three investors about their experience with the ketogenic diet.
Jim Cramer shared his take on the world’s most valuable company ahead of its big quarter.
Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease.